| HCVTX | OCGCX | HCVTX / OCGCX | |
| Total Expense Ratio | 0.75 | 1.44 | 52% |
| Annual Report Gross Expense Ratio | 0.75 | 1.44 | 52% |
| Fund Existence | 19 years | 28 years | - |
| Gain YTD | 10.307 | 8.929 | 115% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 146M | 4.23B | 3% |
| Annual Yield % from dividends | 2.50 | 2.74 | 91% |
| Returns for 1 year | 9.49 | 6.27 | 151% |
| Returns for 3 years | 31.39 | 20.17 | 156% |
| Returns for 5 years | 19.14 | 9.62 | 199% |
| Returns for 10 years | 54.76 | 24.99 | 219% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ZEMAX | 14.92 | -0.16 | -1.06% |
| American Beacon Ninety One Emr Mkts Eq Y | |||
| MEMCX | 38.72 | -0.44 | -1.12% |
| MFS Emerging Markets Equity C | |||
| BGIFX | 15.23 | -0.20 | -1.31% |
| Baillie Gifford International Alpha 3 | |||
| PCLCX | 19.76 | -0.46 | -2.27% |
| PACE Large Co Growth Equity P | |||
| SLCGX | 34.32 | -0.85 | -2.42% |
| Saratoga Large Capitalization Growth I | |||